SearchSkip to Search Results
- 1Adam, Ibrahim S. Y.
- 1Airo, Adriana M
- 1Arendt, Christopher William.
- 1Awadh, Abdullah
- 1Azaizeh, Bara'ah
- 1Bacik, John-Paul
- 8Evans, David (Medical Microbiology and Immunology)
- 5Barry, Michele (Medical Microbiology and Immunology)
- 5Ingham, Robert (Medical Microbiology and Immunology)
- 5Ostergaard, Hanne (Medical Microbiology and Immunology)
- 4Foley, Edan (Medical Microbiology and Immunology)
- 3Baldwin, Troy (Medical Microbiology and Immunology)
One of the most notable features of poxviruses is their ability to regulate cellular signaling pathways, including the ubiquitin-proteasome system. Ubiquitin plays a crucial role in the fate of a protein. Typically poly-ubiquitinated proteins are degraded by the 26S proteasome. The Skp1,...
Vibrio cholerae is the Gram-negative bacterium responsible for the diarrheal disease cholera. In addition to the well-characterized virulence factors – cholera toxin and the toxin co-regulated pilus – used by this organism to cause watery diarrhea, V. cholerae uses the type VI secretion system...
VP16 initiates the HSV replication cycle by activating immediate early (IE) gene expression. It recruits the RNA pol II through an acidic C-terminal domain. The defective VP16 encoded by the V422 mutant of HSV-1 possesses a truncated C-terminal domain. Therefore, V422 replication is suppressed in...
Characterization of the Herpes Simplex Virus 1 VP11/12-tyrosine based binding motifs for Src family kinases, p85, Grb2 and ShcDownload
Infection with HSV-1 triggers several events specifically designed to manipulate cell signal transduction pathways. Two major signaling cascades targeted by the virus are the PI3K/Akt-pathway and the TCR-signaling pathway. Prior to the studies presented in this thesis, it was known that the...
Characterization of the Humoral Immune Response Elicited Against a Prophylactic Vaccine Composed of Recombinant Envelope Glycoproteins from Hepatitis C VirusDownload
A global prophylactic vaccine for Hepatitis C Virus (HCV) remains elusive. The diversity of the virus is a major hurdle; a successful vaccine will need to protect against all 7 HCV genotypes (gt). Our lab is developing a vaccine comprising the two envelope glycoproteins of HCV (E1E2). An...
Viral entry is an attractive antiviral target. Entry inhibitors prevent infection of healthy cells and inhibit viral replication before viruses establish persistent reservoirs. Two entry steps, the primary attachment to cellular glycans and the lipid rearrangements during fusion, are conserved...